New analyses show Novartis' EntrestoTM reduced cardiovascular death or hospitalization forheart failure, consistently benefitting patients with reduced ejection fractionregardless of prior heart failure hospital admissions or background therapy | Novartis
Entresto, INN-sacubitril/valsartan
Entresto: Uses, Dosage, Side Effects & Warnings - Drugs.com